-
About
Personal Statement
Most of the patients we see are either approaching total kidney failure or are on dialysis already. We also see patients with type 1 diabetes who are referred for kidney and pancreas transplantation. So most of our patients need a kidney transplant or are pursuing it as a lifestyle change from dialysis, which I don’t think is a really good lifestyle – it’s very inhibiting.
We also see patients with other organ transplants when something along their transplant course has also injured their kidney. We see them until the kidney injury is improved.
The rewarding thing about transplant is the lifestyle change that the patient gets to go through. The patients feel better. They eat better. They have an overall better lifestyle, and that’s what makes it rewarding.
Faculty Rank
Professor of MedicineDegree
University of Kentucky, College of Medicine
Residency
University of Kentucky
Fellowship
University of Kentucky
Certifications and Special Training
American Board of Internal Medicine
-
Publications
-
T10B9 monoclonal antibody: a short-acting nonstimulating monoclonal antibody that spares gammadelta T-cells and treats and prevents cellular rejection.
Drug Des Devel Ther. 2009; 3:205-12. PMID: 19920935. Waid TH, Thompson JS, Siemionow M, Brown SA.
View Publication -
Treatment of respiratory syncytial virus pneumonia in a lung transplant recipient: case report and review of the literature.
Pharmacotherapy. 2004 Jul; 24(7):932-8. PMID: 15303457. Flynn JD, Akers WS, Jones M, Stevkovic N, Waid T, Mullett T, Jahania S.
View Publication -
Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure.
Am J Kidney Dis. 2003 Feb; 41(2):464-70. PMID: 12552511. Reddy KS, Stablein D, Taranto S, Stratta RJ, Johnston TD, Waid TH, McKeown JW, Lucas BA, Ranjan D.
View Publication -
View all publications on PubMed.
View Publication
-
T10B9 monoclonal antibody: a short-acting nonstimulating monoclonal antibody that spares gammadelta T-cells and treats and prevents cellular rejection.
Drug Des Devel Ther. 2009; 3:205-12. PMID: 19920935. Waid TH, Thompson JS, Siemionow M, Brown SA.
-
Ratings & Reviews
The star rating is a calculation based on feedback from our patients using our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more about our survey process. Responses are measured on a scale of 1 to 5 with 5 being the best score.
January, 2020
Transplant team members very friendly & organized.November, 2019
*Dr. Waid has been my transplant dr. for 13 years. He is the best and most knowledgeable.August, 2019
I have labs done every 2 wks. It's to be sure I'm still stable. So no news is good news. I know if there is a problem, I'd get a phone call immediately.August, 2019
I have been extremely pleased with the care provided to me by *Dr. Waid since my transplant 5 years ago.Are you happy with the care you received from this provider?Please let us know by filling out a patient satisfaction survey when you get one. You can also leave an online review by clicking the button below.
-
Podcasts
Becoming a Living Donor: You Can Help A Family Member or A Stranger
-
Locations
Nephrology, Bone & Mineral Metabolism
UK Good Samaritan Professional Arts Center
135 E. Maxwell St.
Fourth Floor, Suite 401
Lexington, KY 40508Call 859-323-2663Insurance Information
Insurance policies can vary widely. Please check with your doctor/clinic for specific insurance information before your visit or procedure to avoid unexpected out-of-pocket costs. See list of insurers
-